Jakavi 5 mg
Generic Brands | Ruxolitinib |
---|---|
Manufacturer | Novartis |
Strength | 5 mg |
PharmaceuticalForm | Tablet/s |
Delivery Time | 6 To 15 days |
Generic Brands | Ruxolitinib |
---|---|
Manufacturer | Novartis |
Strength | 5 mg |
PharmaceuticalForm | Tablet/s |
Delivery Time | 6 To 15 days |
Jakavi 5mg pill is a type of kinase inhibitor used to treat bone marrow problems like myelofibriosis and polycythemia vera in case there is an inadequate response or intolerance towards hydroxyurea. Its mechanism involves blocking substances involved in myelofibriosis, like JAK1 and JAK2.
Ruxolitinib
Novartis India Ltd
Jakavi 5mg pill is used in the treatment of chronic idiopathic myelofibrosis.
Jakavi 5mg medicine belongs to the group of medicament called antineoplastics, or anti-cancer medications. Jakavi 5mg pill, an oral medicament , contains Ruxolitinib as an active ingredient. It is a prescription medicine that should be used under proper medical guidance and advice. Do not share the drug with others, since they may be suffering from a problem that is not effectively treated by this medicine.
Jakavi 5mg Tablet is an anti-cancer medication. It works by blocking the function of the abnormal protein that signals cancer cells to grow. This helps to pause or slow the circulation of cancer cells.
Take this drug in the dose and duration as advised by your health care physician. Swallow it as a whole. Do not chew, crush or break it. Jakavi 5mg pill may be taken with or without food, but it is better to take it at a fixed time.
Take this medicine with or without food. Do not take in larger or little amounts than advised/prescribed. Your dose is likely to change during the duration of the therapy based on your clinical condition and therapeutic response. Consult the health care physician if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this drug without consulting your health care physician.
Jakavi 5mg pill may be unsafe to use during pregnancy. Animal studies have shown hostile havings on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the danger. Please consult your doctor.
Jakavi 5mg pill is probably unsafe to use during lactation. Limited human data suggest that the medicine could represent a significant risk to the baby.
Do not give Jakavi 5mg pill to seed aged below 18 years.
Do not drive or intersect machinery after using Jakavi 5mg Tablet as it may cause dizziness.
Store Jakavi 5mg Tablet in a cool and dry place Discard the medicine if its expiry date has crossed.
Keep this cancer drug away from the reach of seed or pets.